Navigation Links
IMA ACB Test Controls

ProductsIMA ACB Test Controls
Company Inverness Medical Innovations
Item IMA ACB Test Controls
Features Inquire
Description The Albumin Cobalt Binding (ACB®) Test is a clinical chemistry assay that detects Ischemia Modified Albumin (IMA®) by measuring the cobalt binding capacity of albumin in a patient serum sample. First identified in the early 1990s, IMA is produced when circulating albumin comes in contact with ischemic tissue in the heart. During ischemia, the N-terminus of albumin is altered through a series of chemical reactions that cause free radical damage to albumin. This altered albumin is produced continually during ischemia. IMA concentrations in blood rise quickly and remain elevated during an ischemic event, returning to normal level several hours after cessation of ischemia. IMA can be used in conjunction with electrocardiogram (ECG) and troponin as an aid to rule out ACS at presentation-saving time, resources and money.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Bartels® C. Difficile Toxin A Antigen EIA with Controls
2. Liquid Assayed and Unassayed Multiqual Controls
3. Liquichek Autoimmune Controls - ANA
4. Amplichek CT/GC Controls
5. Liquichek ToRCH Plus Controls
6. Liquichek ToRCH Plus IgM Controls
7. Liquichek Autoimmune Controls - Anti-Sm
8. Liquichek Autoimmune Controls - Anti-SS
9. Liquichek Autoimmune Controls - Anti-Scl-70
10. Liquichek Autoimmune Controls - Anti-RNP
11. Liquichek Autoimmune Controls - Anti-Mitochondrial
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 130o....
Wedge-shaped chopper designed to allow nucleus chopping in three directions, tip length 1.25 mm. Rounded tip highly polished to protect the posterior capsule. 0.5 mm spatula end is used to manipulate...
Angled blade and flat serrated handle with polished finish. Blade: 1 mm x 10 mm....
10 mm angled tip with indentation on side and gently curved blade. Round knurled handle with polished finish. Indentation: right side....
Medicine Products:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: